Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
fda
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
2
×
akcea therapeutics
alder biopharmaceuticals
alnylam pharmaceuticals
amgen
andrew fire
biotech
boston
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
craig mello
david rind
detroit blog main
detroit top stories
eli lilly
episodic migraine
eptinezumab
erenumab
food and drug administration
fremanezumab
galcanezumab
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
inotersen
institute for clinical and economic review
What
drug
fda
2
×
gets
2
×
afternoon
alnylam
alnylam’s
amgen
approval
approved
candidates
class
developed
head
history
landmark
making
medicine
medicines
migraine
new
nod
ok
onpattro
pain
patisiran
pharmaceuticals
preventive
rnai
specifically
starts
won
Language
Current search:
fda
×
gets
×
" san francisco top stories "
×
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
